Centene CorporationCNCEarnings & Financial Report
Centene Corporation is an American for-profit healthcare company based in the Greater St. Louis area, which is an intermediary for government-sponsored and privately insured healthcare programs. Centene ranked No. 23 on the 2025 Fortune 500.
CNC Q1 FY2026 Key Financial Metrics
Revenue
$49.9B
Gross Profit
N/A
Operating Profit
$1.9B
Net Profit
$1.5B
Gross Margin
N/A
Operating Margin
3.7%
Net Margin
3.1%
YoY Growth
7.1%
EPS
$3.11
Centene Corporation Q1 FY2026 Financial Summary
Centene Corporation reported revenue of $49.9B (up 7.1% YoY) for Q1 FY2026, with a net profit of $1.5B (up 17.1% YoY) (3.1% margin).
Key Financial Metrics
| Total Revenue | $49.9B |
|---|---|
| Net Profit | $1.5B |
| Gross Margin | N/A |
| Operating Margin | 3.7% |
| Report Period | Q1 FY2026 |
Revenue Breakdown
Centene Corporation Q1 FY2026 revenue of $49.9B breaks down across 3 segments, led by Premium at $43.9B (87.9% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Premium | $43.9B | 87.9% |
| Premium tax | $5.3B | 10.6% |
| Service | $768.0M | 1.5% |
Centene Corporation Annual Revenue by Year
Centene Corporation annual revenue history includes year-by-year totals (for example, 2025 revenue was $174.6B).
Centene Corporation Quarterly Revenue & Net Profit History
Centene Corporation results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2026 | $49.9B | +7.1% | $1.5B | 3.1% |
| Q4 FY2025 | $44.7B | +23.2% | $-1.1B | -2.5% |
| Q3 FY2025 | $44.9B | +21.7% | $-6.6B | -14.8% |
| Q2 FY2025 | $42.5B | +18.1% | $-253.0M | -0.6% |
| Q1 FY2025 | $42.5B | +16.9% | $1.3B | 3.1% |
| Q4 FY2024 | $36.3B | +2.7% | $283.0M | 0.8% |
| Q3 FY2024 | $36.9B | +5.5% | $713.0M | 1.9% |
| Q2 FY2024 | $36.0B | +3.3% | $1.1B | 3.2% |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $35.97B | $36.90B | $36.30B | $42.49B | $42.47B | $44.90B | $44.73B | $49.94B |
| YoY Growth | 3.3% | 5.5% | 2.7% | 16.9% | 18.1% | 21.7% | 23.2% | 7.1% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $83.14B | $82.35B | $82.44B | $87.04B | $86.39B | $82.09B | $76.75B | $81.17B |
| Liabilities | $55.68B | $54.94B | $55.94B | $59.02B | $58.89B | $61.03B | $56.69B | $59.65B |
| Equity | $27.35B | $27.31B | $26.41B | $27.92B | $27.41B | $20.95B | $19.95B | $21.50B |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $2.17B | $-978.0M | $-587.0M | $1.51B | $1.78B | $1.36B | $437.0M | $4.37B |